JAGSNPHARM

HealthcareDrug Manufacturers - Specialty & GenericSmall Cap
Jagsonpal Pharmaceuticals Limited

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) operates in the Healthcare sector, specifically as a Drug Manufacturer of Specialty & Generic products. The company manufactures, sel...

हिन्दी में

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) हेल्थकेयर सेक्टर में काम करती है, विशेष रूप से स्पेशलिटी और जेनेरिक ड्रग्स की निर्माता है। कंपनी भारत और अंतरराष्ट्रीय स्तर पर फार्मा...

₹225.6-2.63%1D
Previous trading day close · Data updates after market close
1W: -1.7%
1M: -4.2%
6M: +15.9%
1Y: +4.7%
64/100
AverageResearch Score
Market Cap
₹1.5K Cr
Small Cap
P/E Ratio
36.16
Fair
P/B Ratio
6.49
Premium
ROE
25.9%
Strong
ROCE
23.2%
Excellent
Debt / Equity
0.04
Low debt
Div. Yield
1.7%
Low yield
EV/EBITDA
21.15
Fair
52W Low: ₹155Current: ₹225.652W High: ₹264.5
At 64% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
80/100
Growth
Revenue, EPS, profit growth
63/100
Valuation
PE, PB, EV/EBITDA vs sector
35/100
Risk
Debt levels, volatility, coverage
80/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
36.16(Fair)
Forward P/E
N/A
P/B Ratio
6.49(Premium)
P/S Ratio
5.21(Expensive)
EV/EBITDA
21.15(Expensive)
Dividend Yield
1.7%
5Y CAGR
31.2%(High growth)
Revenue Growth
-0.3%(Moderate)
Profitability
ROE
25.9%(Excellent)
ROCE
23.2%(Excellent)
ROA
22.4%(Efficient)
Net Margin
14.4%(Decent)
EBITDA Margin
22.7%
Financial Health
Debt to Equity
0.04(Low debt)
Current Ratio
6.22(Healthy)
Quick Ratio
5.64(Good)
Interest Coverage
56.84x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
48(Neutral)
RSI Exp (14)
26(Oversold)
MACD
-0.715(Bearish)
MACD Signal
-0.095
BB Position
22%(Middle)
BB Width
9.92%(Normal)
ADX (14)
12.1(Sideways)
Williams %R
-85.9(Oversold)
MFI (14)
91(Overbought)
CCI (20)
-70(Neutral)
Stoch %K
14(Oversold)
ATR (14)
10.12(Avg True Range)
OBV (M)
67.2(Positive)
1W OBV Chg
-0.0%(Decreasing)
Rel Volume
0.11x(Low activity)
Volatility
50.0%(High)
Max DD 1Y
-47.1%(High loss)
EMA 200
218.7
EMA 50
231.9
SMA 200
206.3
vs SMA 50
-3.7%(Below SMA50)
vs SMA 200
9.3%(Above SMA200)
Volume
50.9K
Avg Vol 3M
4.8L
Shareholding Pattern
Promoter
69.4%
High confidence
FII
2.5%
DII / MF
0.3%
Share JAGSNPHARM
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.